ChronoScale Holdings Corp (CHRN) reported that its Chief Financial Officer, Jerome Wong, received a grant of 300,000 restricted stock units (RSUs) on August 16, 2026. These RSUs convert into common shares on a one-for-one basis, have no expiration date, and vest one-third on May 5, 2027, with additional one-sixth installments every six months until full vesting on May 5, 2029, subject to continued service and potential accelerated vesting under certain conditions.
After this award, Wong holds 364,771 shares of common stock directly, which include 40,000 shares from vested performance-based RSUs and 24,771 shares from previously granted RSUs adjusted for a 1-for-15 reverse stock split, plus 4,184 shares indirectly via a 401(k) plan.
Jegannathan Rajasekar reported acquisition or exercise transactions in this Form 4 filing.
ChronoScale Holdings Corp Chief Technology Officer Jegannathan Rajasekar received a grant of 1,400,000 restricted stock units on July 22, 2026. The RSUs represent a contingent right to common shares and vest from June 1, 2027 through June 1, 2029, subject to continuous service, bringing his direct holdings to 1,402,587 shares.
ChronoScale Holdings Corp reports the initial equity holdings of Chief Technology Officer Jegannathan Rajasekar. As of 2026-07-19, he directly owns 2,587.0000 shares of Common Stock; the report characterizes this as a holding entry rather than a new transaction.
Chen Ying Cenly reported acquisition or exercise transactions in this Form 4 filing.
ChronoScale Holdings Corp granted Chief Executive Officer Chen Ying Cenly 2,800,000 restricted stock units (RSUs) tied to its common stock on July 13, 2026. The RSUs have no expiration date and vest one-third on May 1, 2027, then in equal six-month installments until fully vested on May 1, 2029, subject to continuous service and possible accelerated vesting under certain conditions. Following the award, Cenly’s reported direct beneficial ownership is 2,800,000 shares.
ChronoScale Holdings Corporation filed a pre-effective amendment to an S-3 registration covering the resale of 1,097,509 shares of common stock previously issued or issuable from private placements. These shares include common issued or issuable upon conversion of Series B preferred stock and exercise of investor and placement agent warrants.
The company will not receive proceeds from sales by the selling stockholders. ChronoScale now operates primarily a cloud business providing GPU-based infrastructure for AI and machine learning workloads, alongside its Legacy Ekso exoskeleton segment, which is classified as held for sale with divestiture targeted by the first fiscal quarter of 2027.
The filing also reflects ChronoScale Holdings’ status as successor issuer after a July 2026 Nevada holding company reorganization and describes significant risks, including large historical net losses, dependence on a single cloud customer expected to represent 99.5% of revenue for the year ended May 31, 2026, reliance on a few GPU suppliers, expected future capital needs and potential shareholder dilution.
ChronoScale Corporation is registering 1,097,509 shares of common stock for resale by selling stockholders pursuant to this prospectus. The resale covers shares issuable upon conversion and warrants from private placements, and the company will receive no proceeds from these resales.
The prospectus lists the sources of the Shares as: 15,389 2025 Placement Agent Warrant Shares; 711,922 Conversion Shares from Series B Preferred conversions; 355,960 Investor Warrant Shares; and 14,238 2026 Placement Agent Warrant Shares. The prospectus states there were 145,214,825 shares outstanding as of June 25, 2026.
Schaap Andrew Cordell reported acquisition or exercise transactions in this Form 4 filing.
ChronoScale Corp director Andrew Cordell Schaap received an equity grant of 200,000 shares of Common Stock as restricted stock. The grant was made on June 29, 2026 at a stated price of $0.00 per share and brings his reported direct holdings to 200,000 shares.
The award vests in two equal installments: 100,000 restricted shares vest on the one-year anniversary of the June 29, 2026 grant date and 100,000 restricted shares vest on the two-year anniversary. Vesting requires his continuous service with ChronoScale through each vesting date, with potential adjustment or accelerated vesting under certain conditions.
ChronoScale Corp director Schaap Andrew Cordell filed an initial Form 3, which is a required statement of beneficial ownership for insiders. This filing shows no reported transactions, derivative positions, or current holdings, serving mainly to formally register Schaap as an insider for future ownership reporting.
ChronoScale Corporation filed Amendment No. 2 to its current report to add detailed financial statements for its Applied Digital Cloud (“Cloud”) business and pro forma results following the recent Business Combination. Cloud provides GPU-based cloud services and has grown quickly but remains loss‑making and capital intensive.
For the fiscal year ended May 31, 2025, Cloud generated $84.4 million in revenue, up sharply from $29.0 million a year earlier, yet recorded a net loss of $72.7 million and operating loss of $55.3 million. For the nine months ended February 28, 2026, revenue was $53.2 million with a net loss of $32.8 million, reflecting the loss of a customer and heavy lease and interest expenses.
The filings highlight significant lease obligations and prior working capital deficits, with Cloud historically relying on its former parent for financing. Management discloses that substantial doubt about continuing as a going concern was raised but believes this has been alleviated through lease renegotiations, strong operating cash flow in the latest nine-month period, and a $15.8 million private placement completed alongside the Business Combination.